152 related articles for article (PubMed ID: 26363409)
1. Ex vivo lymphocyte phenotyping during Plasmodium falciparum sporozoite immunization in humans.
Bijker EM; Schats R; Visser LG; Sauerwein RW; Scholzen A
Parasite Immunol; 2015 Nov; 37(11):590-8. PubMed ID: 26363409
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic markers associate with protection against malaria in human volunteers immunized with Plasmodium falciparum sporozoites.
Bijker EM; Teirlinck AC; Schats R; van Gemert GJ; van de Vegte-Bolmer M; van Lieshout L; IntHout J; Hermsen CC; Scholzen A; Visser LG; Sauerwein RW
J Infect Dis; 2014 Nov; 210(10):1605-15. PubMed ID: 24872326
[TBL] [Abstract][Full Text] [Related]
3. Modest heterologous protection after Plasmodium falciparum sporozoite immunization: a double-blind randomized controlled clinical trial.
Walk J; Reuling IJ; Behet MC; Meerstein-Kessel L; Graumans W; van Gemert GJ; Siebelink-Stoter R; van de Vegte-Bolmer M; Janssen T; Teelen K; de Wilt JHW; de Mast Q; van der Ven AJ; Diez Benavente E; Campino S; Clark TG; Huynen MA; Hermsen CC; Bijker EM; Scholzen A; Sauerwein RW
BMC Med; 2017 Sep; 15(1):168. PubMed ID: 28903777
[TBL] [Abstract][Full Text] [Related]
4. Detection of CD4+CD45RO+ T lymphocytes producing IL-4 in response to antigens on Plasmodium falciparum erythrocytes: an in vitro correlate of protective immunity induced with attenuated Plasmodium falciparum sporozoites.
Bergmann ES; Ballou RW; Krzych U
Cell Immunol; 1997 Sep; 180(2):143-52. PubMed ID: 9341744
[TBL] [Abstract][Full Text] [Related]
5. Sporozoite immunization of human volunteers under chemoprophylaxis induces functional antibodies against pre-erythrocytic stages of Plasmodium falciparum.
Behet MC; Foquet L; van Gemert GJ; Bijker EM; Meuleman P; Leroux-Roels G; Hermsen CC; Scholzen A; Sauerwein RW
Malar J; 2014 Apr; 13():136. PubMed ID: 24708526
[TBL] [Abstract][Full Text] [Related]
6. Systems analysis of immune responses to attenuated P. falciparum malaria sporozoite vaccination reveals excessive inflammatory signatures correlating with impaired immunity.
Du Y; Hertoghs N; Duffy FJ; Carnes J; McDermott SM; Neal ML; Schwedhelm KV; McElrath MJ; De Rosa SC; Aitchison JD; Stuart KD
PLoS Pathog; 2022 Feb; 18(2):e1010282. PubMed ID: 35108339
[TBL] [Abstract][Full Text] [Related]
7. The Complement System Contributes to Functional Antibody-Mediated Responses Induced by Immunization with Plasmodium falciparum Malaria Sporozoites.
Behet MC; Kurtovic L; van Gemert GJ; Haukes CM; Siebelink-Stoter R; Graumans W; van de Vegte-Bolmer MG; Scholzen A; Langereis JD; Diavatopoulos DA; Beeson JG; Sauerwein RW
Infect Immun; 2018 Jul; 86(7):. PubMed ID: 29735521
[TBL] [Abstract][Full Text] [Related]
8. Skin scarification with Plasmodium falciparum peptide vaccine using synthetic TLR agonists as adjuvants elicits malaria sporozoite neutralizing immunity.
Mitchell RA; Altszuler R; Frevert U; Nardin EH
Sci Rep; 2016 Sep; 6():32575. PubMed ID: 27624667
[TBL] [Abstract][Full Text] [Related]
9. Exploring immunological mechanisms of the whole sporozoite vaccination against P. falciparum malaria.
Mo AX; Pesce J; Hall BF
Vaccine; 2015 Jun; 33(25):2851-7. PubMed ID: 25917675
[TBL] [Abstract][Full Text] [Related]
10. Protection against malaria after immunization by chloroquine prophylaxis and sporozoites is mediated by preerythrocytic immunity.
Bijker EM; Bastiaens GJ; Teirlinck AC; van Gemert GJ; Graumans W; van de Vegte-Bolmer M; Siebelink-Stoter R; Arens T; Teelen K; Nahrendorf W; Remarque EJ; Roeffen W; Jansens A; Zimmerman D; Vos M; van Schaijk BC; Wiersma J; van der Ven AJ; de Mast Q; van Lieshout L; Verweij JJ; Hermsen CC; Scholzen A; Sauerwein RW
Proc Natl Acad Sci U S A; 2013 May; 110(19):7862-7. PubMed ID: 23599283
[TBL] [Abstract][Full Text] [Related]
11. Potent induction of focused Th1-type cellular and humoral immune responses by RTS,S/SBAS2, a recombinant Plasmodium falciparum malaria vaccine.
Lalvani A; Moris P; Voss G; Pathan AA; Kester KE; Brookes R; Lee E; Koutsoukos M; Plebanski M; Delchambre M; Flanagan KL; Carton C; Slaoui M; Van Hoecke C; Ballou WR; Hill AV; Cohen J
J Infect Dis; 1999 Nov; 180(5):1656-64. PubMed ID: 10515829
[TBL] [Abstract][Full Text] [Related]
12. Recombinant Liver Stage Antigen-1 (LSA-1) formulated with AS01 or AS02 is safe, elicits high titer antibody and induces IFN-gamma/IL-2 CD4+ T cells but does not protect against experimental Plasmodium falciparum infection.
Cummings JF; Spring MD; Schwenk RJ; Ockenhouse CF; Kester KE; Polhemus ME; Walsh DS; Yoon IK; Prosperi C; Juompan LY; Lanar DE; Krzych U; Hall BT; Ware LA; Stewart VA; Williams J; Dowler M; Nielsen RK; Hillier CJ; Giersing BK; Dubovsky F; Malkin E; Tucker K; Dubois MC; Cohen JD; Ballou WR; Heppner DG
Vaccine; 2010 Jul; 28(31):5135-44. PubMed ID: 19737527
[TBL] [Abstract][Full Text] [Related]
13. A linear peptide containing minimal T- and B-cell epitopes of Plasmodium falciparum circumsporozoite protein elicits protection against transgenic sporozoite challenge.
Calvo-Calle JM; Oliveira GA; Watta CO; Soverow J; Parra-Lopez C; Nardin EH
Infect Immun; 2006 Dec; 74(12):6929-39. PubMed ID: 17030584
[TBL] [Abstract][Full Text] [Related]
14. Heterologous Protection against Malaria after Immunization with Plasmodium falciparum Sporozoites.
Schats R; Bijker EM; van Gemert GJ; Graumans W; van de Vegte-Bolmer M; van Lieshout L; Haks MC; Hermsen CC; Scholzen A; Visser LG; Sauerwein RW
PLoS One; 2015; 10(5):e0124243. PubMed ID: 25933168
[TBL] [Abstract][Full Text] [Related]
15. Sporozoite immunization of human volunteers under mefloquine prophylaxis is safe, immunogenic and protective: a double-blind randomized controlled clinical trial.
Bijker EM; Schats R; Obiero JM; Behet MC; van Gemert GJ; van de Vegte-Bolmer M; Graumans W; van Lieshout L; Bastiaens GJ; Teelen K; Hermsen CC; Scholzen A; Visser LG; Sauerwein RW
PLoS One; 2014; 9(11):e112910. PubMed ID: 25396417
[TBL] [Abstract][Full Text] [Related]
16. Immunization of Malaria-Preexposed Volunteers With PfSPZ Vaccine Elicits Long-Lived IgM Invasion-Inhibitory and Complement-Fixing Antibodies.
Zenklusen I; Jongo S; Abdulla S; Ramadhani K; Lee Sim BK; Cardamone H; Flannery EL; Nguyen T; Fishbaugher M; Steel RWJ; Betz W; Carmago N; Mikolajczak S; Kappe SHI; Hoffman SL; Sack BK; Daubenberger C
J Infect Dis; 2018 Apr; 217(10):1569-1578. PubMed ID: 29438525
[TBL] [Abstract][Full Text] [Related]
17. Memory B-cell and antibody responses induced by Plasmodium falciparum sporozoite immunization.
Nahrendorf W; Scholzen A; Bijker EM; Teirlinck AC; Bastiaens GJ; Schats R; Hermsen CC; Visser LG; Langhorne J; Sauerwein RW
J Infect Dis; 2014 Dec; 210(12):1981-90. PubMed ID: 24970846
[TBL] [Abstract][Full Text] [Related]
18. The Development of Whole Sporozoite Vaccines for
Itsara LS; Zhou Y; Do J; Grieser AM; Vaughan AM; Ghosh AK
Front Immunol; 2018; 9():2748. PubMed ID: 30619241
[TBL] [Abstract][Full Text] [Related]
19. Humanized DRAGA mice immunized with Plasmodium falciparum sporozoites and chloroquine elicit protective pre-erythrocytic immunity.
Majji S; Wijayalath W; Shashikumar S; Brumeanu TD; Casares S
Malar J; 2018 Mar; 17(1):114. PubMed ID: 29540197
[TBL] [Abstract][Full Text] [Related]
20. Protection against a malaria challenge by sporozoite inoculation.
Roestenberg M; McCall M; Hopman J; Wiersma J; Luty AJ; van Gemert GJ; van de Vegte-Bolmer M; van Schaijk B; Teelen K; Arens T; Spaarman L; de Mast Q; Roeffen W; Snounou G; Rénia L; van der Ven A; Hermsen CC; Sauerwein R
N Engl J Med; 2009 Jul; 361(5):468-77. PubMed ID: 19641203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
